ISMPP Highlights
Wager’s Wonders and Words of Wisdom
Elizabeth (Liz) Wager has been an insightful, industrious, and influential contributor to our profession. If you know Liz, you will be nodding your head. If you don’t know Liz, you need to type ”Liz Wager” into Google, and you can then join the nodders. What Google won’t tell you (yet) is that…
Global Transparency & Trends Committee Conducts ISMPP Member Survey
In 2017, The MAP newsletter introduced the membership to the ISMPP Global Transparency & Trends Committee (GTTC), which aims to keep members updated on recent developments and current best practices for data and financial transparency. One of the Committee remits was to better understand…
Medical Writer Joint Position Statement Recognized Worldwide
Over the past several months, the Joint Position Statement on the Role of Professional Medical Writers (JPS) has received various organizational endorsements, has had related journal articles published about it, and has been translated into new languages…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Medical Writers Worth Their Weight in Gold
The question of how much value professional medical writers add to the development of medical publications has arisen regularly over the past couple of decades, and recent studies have aimed to provide an answer. The AMWA, EMWA, and ISMPP Joint Position Statement on the Role of Professional Medical Writers went a step further to describe…
Are Calls for Greater Openness in Reporting Preclinical Research an Opportunity for Publication Professionals?
Calls for urgent improvements in the design, registration, reporting, and transparency of preclinical studies have recently arisen. In an open letter to the USA Today newspaper published June 20, 2018, over 500 researchers, including four Nobel Laureates, called for…
Salt, Louis IV, and HEOR: A Focus on Three Trends in Publication Planning
Publication professionals work in an industry experiencing a shift in required evidence related to a product’s value, as well as its safety and efficacy. They manage the release of clinical and economic data that can improve the lives of billions of people globally. That is the easy part…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: The Authorship Order Dilemma
You are a company medical publication professional. The publication steering committee of a company-sponsored pivotal phase 3 clinical trial has selected investigators to serve as authors, but the committee and authors are having difficulty in deciding the order of authorship. During discussions, multiple authors believe that they have equal rights to the first author position based on their contributions. What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals